BEST-MS: A Standardized and Prospective Study Comparing the Efficacy of Natalizumab versus Fingolimod in Active Relapsing Multiple Sclerosis.

Affiliation auteurs!!!! Error affiliation !!!!
TitreBEST-MS: A Standardized and Prospective Study Comparing the Efficacy of Natalizumab versus Fingolimod in Active Relapsing Multiple Sclerosis.
Type de publicationJournal Article
Year of Publication2020
AuteursCohen M, Mondot L, Bucciarelli F, Pignolet B, Laplaud D, Brochet B, Defer G, Derache N, Vermersch P, Zephir H, Debouverie M, Berger E, Labauge P, Ayrignac X, de Seze J, Brassat D, Lebrun-Frenay C
JournalNEUROLOGY
Volume94
Date PublishedAPR 14
Type of ArticleMeeting Abstract
ISSN0028-3878